Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Quality indicators for capsule endoscopy and deep enteroscopy.
Journal: Gastrointestinal endoscopy
Published: August 31, 2022
Quality Indicators for Capsule Endoscopy and Deep Enteroscopy.
Journal: The American journal of gastroenterology
Published: July 06, 2022
Benchmarking Adenoma Detection Rates for Colonoscopy: Results From a US-Based Registry.
Journal: The American journal of gastroenterology
Published: February 22, 2021
Variation Over Time and Factors Associated With Detection Rates of Sessile Serrated Lesion Across the United States: Results Form a National Sample Using the GIQuIC Registry.
Journal: The American journal of gastroenterology
Published: November 27, 2019
Quality indicators for gastrointestinal endoscopy units.
Journal: VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy
Published: June 16, 2018
ASGE guideline for infection control during GI endoscopy.
Journal: Gastrointestinal endoscopy
Published: December 15, 2017
Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett's Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium.
Journal: The American journal of gastroenterology
Published: June 02, 2017
Increased detection of Barrett's esophagus-associated neoplasia using wide-area trans-epithelial sampling: a multicenter, prospective, randomized trial.
Journal: Gastrointestinal endoscopy
Published: May 12, 2017
Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium.
Journal: Gastrointestinal endoscopy
Published: March 06, 2017
Multisociety guideline on reprocessing flexible GI endoscopes: 2016 update.
Journal: Gastrointestinal endoscopy
Published: October 03, 2016
Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk.
Journal: Cardiovascular therapeutics
Published: January 05, 2016
Last Updated: 09/26/2026